35 episodes
JAMA Health Forum Editors' Summary JAMA Network
-
- Health & Fitness
-
-
5.0 • 1 Rating
-
JAMA Health Forum is a peer-reviewed, open-access JAMA Network journal focused on health policy. The journal publishes original research, evidence-based reports, and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity, and reform. The podcast highlights new articles and their authors as well as the latest news in health policy for a broad audience interested in improving health and health care in the United States and globally.
-
Trends in Smoking Among US Adults From 2011 to 2022
Smoking remains a leading cause of preventable morbidity and mortality in the US. Rafael Meza, PhD, of the British Columbia Cancer Research Institute, discusses recent trends in smoking by US adults across different age and income groups in this interview with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD.
Related Content:
Trends in US Adult Smoking Prevalence, 2011 to 2022 -
The History, Economics, and Policy Context of Pharmacy Benefit Managers
JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, speak with Ge Bai, PhD, CPA, author of Pharmacy Benefit Managers: History, Business Practices, Economics, and Policy, about how pharmacy benefit managers (PBMs) have evolved in recent decades to play a central role in the US prescription drug market, including the benefits and policy challenges that PBMs present in this market.
Related Content:
Pharmacy Benefit Managers -
Economic Burden of Untreated Mental Illness in Indiana
JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, spoke with Heather Taylor, MD, from Indiana University Richard M. Fairbanks School of Public Health, about the costs of untreated mental illness in the state of Indiana. Considering a wide set of direct and indirect costs, her team estimated the cost to Indiana is over $4 Billon per year.
Related Content:
Economic Burden Associated With Untreated Mental Illness in Indiana -
Innovative Approach to Promote Equitable Access to COVID-19 Preventive Therapy
In this interview, JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, explore with Erin K. McCreary, PharmD, and Atheendar S. Venkataramani, MD, PhD, how a large regional health system used a weighted lottery and intensive outreach to provide high-risk individuals in disadvantaged communities more equitable access to scarce monoclonal antibodies for preventing COVID-19.
Related Content:
Weighted Lottery to Equitably Allocate Scarce Supply of COVID-19 Monoclonal Antibody Moving Beyond Intent and Realizing Health Equity -
How Safe Were Kids in School During Phases of the Pandemic?
JAMA Health Forum Editor John Ayanian, MD, and Deputy Editor Melinda Buntin, PhD, discuss with Sandra B. Nelson, MD (Massachusetts General Hospital, Boston), her JAMA Health Forum study of transmission of SARS-CoV-2 in schools in Massachusetts during 2 different phases of the COVID-19 pandemic. She found transmission rates were very low but varied by district and the availability of vaccines.
Related Content:
Prevalence and Risk Factors for School-Associated Transmission of SARS-CoV-2 -
FDA Advisory Committees for New Prescription Drugs
JAMA Health Forum Editor John Ayanian, MD, MPP, and Associate Editor Julie Donohue, PhD, speak with Aaron S. Kesselheim, MD, JD, MPH, and Genevieve P. Kanter, PhD, about the role of advisory committees convened by the US Food and Drug Administration (FDA) to guide its decisions on whether to approve new prescription drugs. They also consider how the FDA has responded to recommendations from these advisory committees over the past decade.
Related Content:
Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021 The Real Question the FDA Is Asking Its Advisory Committees